Safety, Tolerability, Pharmacokinetics, and Food Effect Study of RV299 in Healthy Adults

Condition:   Respiratory Syncytial Virus Infections Interventions:   Drug: RV299;   Drug: Placebo;   Drug: Midazolam Sponsor:   Pfizer Completed

Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials